Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114CKazuhiko Mishima, Haruhiko Fukuda, Minako Sumi et al.|Neuro-Oncology|2022Cited by 29
Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant and adjuvant temozolomide in patients with newly diagnosed primary central nervous system lymphoma: JCOG1114C.Kazuhiko Mishima, Haruhiko Fukuda, Ryo Nishikawa et al.|Journal of Clinical Oncology|2020Cited by 9